• SD Biotechnologies’ planned delisting and liquidation trading process was put on hold pending a court decision.
• The pause followed a disclosed injunction request on Oct. 7 seeking to suspend the effectiveness of the delisting decision.
• The exchange had previously notified investors on Oct. 6 that delisting and liquidation trading would proceed due to delisting grounds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SD Biotechnologies Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261007900345), on October 07, 2026, and is solely responsible for the information contained therein.